A double-blind controlled study of the use of diethylpropion hydrochloride (Tenuate) in obese patients in a rural practice.
作者信息
Elliott B J
出版信息
N Z Med J. 1978 Oct 25;88(622):321-2.
PMID:282482
Abstract
A double-blind, placebo-controlled, cross-over study has been carried out to compare long-acting diethylpropion hydrochloride (Tenuate Dospan, Wm. S. Merrell Company, hereafter referred to as TD) in a rural general practice. TD was found to produce significantly more weight loss than placebo and side effects were not significantly greater. The need for the treatment of obese patients in general practice is discussed, as is the role of anorexiant therapy.
摘要
相似文献
1
A double-blind controlled study of the use of diethylpropion hydrochloride (Tenuate) in obese patients in a rural practice.
N Z Med J. 1978 Oct 25;88(622):321-2.
2
Double blind evaluation of long acting diethylpropion hydrochloride in obese patients from a general practice.全科医疗中肥胖患者使用长效盐酸二乙胺苯丙酮的双盲评估
Med J Aust. 1975 Jan 4;1(1):13-5.
3
Controlled-release diethylpropion hydrochloride used in a program for weight reduction.
Clin Ther. 1981;3(5):329-35.
4
Diethylpropion hydrochloride (Tenuate Dospan) in combination with hypotensive agents in the treatment of obesity associated with hypertension.
Curr Ther Res Clin Exp. 1974 May;16(5):398-413.
5
[Weight reduction in obese diabetics: a double-blind study of diethylpropionate (author's transl)].
Wien Klin Wochenschr. 1979 Jun 22;91(13):455-8.
6
A comparative study of phentermine and diethylpropion in the treatment of obese patients in general practice.苯丁胺与二乙丙胺治疗全科肥胖患者的比较研究。
Pharmatherapeutica. 1983;3(5):300-4.
7
Letter: Diethylpropion hydrochlorida (Tenuate Dospan) in the treatment of obese hypertensive patients.
S Afr Med J. 1974 Mar 23;48(14):569.
8
9
A double-blind evaluation of Tenuate dospan in overweight patients from a private gynecologic practice.
J Med Assoc State Ala. 1968 Sep;38(3):209-12.
10
Tenuate dospan as an appetitie suppressant in the treatment of obese children.
Appl Ther. 1970 May;12(5):34-6.
引用本文的文献
1
Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients.安非拉酮和马吲哚作为单一疗法治疗肥胖或超重患者的疗效和安全性的系统评价与荟萃分析。
Clinics (Sao Paulo). 2017 May;72(5):317-324. doi: 10.6061/clinics/2017(05)10.
Zotero 插件